pamidronate has been researched along with Thyrotoxicosis in 1 studies
Thyrotoxicosis: A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tan, TT | 1 |
| Alzaid, AA | 1 |
| Sutcliffe, N | 1 |
| Gardner, MD | 1 |
| Thomson, JA | 1 |
| Boyle, IT | 1 |
1 other study available for pamidronate and Thyrotoxicosis
| Article | Year |
|---|---|
Treatment of hypercalcaemia in thyrotoxicosis with aminohydroxypropylidene diphosphonate.
Topics: Adult; Diphosphonates; Female; Humans; Hypercalcemia; Infusions, Intravenous; Male; Pamidronate; Thy | 1988 |